Immunic (IMUX) Other Accumulated Expenses (2013 - 2026)
Immunic's Other Accumulated Expenses was $743,000 in Q2 2026, down 43.2% from $1.31 million a year earlier and down 84.9% from the prior quarter.
Powered by 
Analysis
Immunic (IMUX) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Immunic came in at $1.84 million, up 29.6% from FY2024.
- Other Accumulated Expenses has now increased for five consecutive years, with a five-year compound annual growth rate of 37.1% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $1.42 million in FY2024 (+46.6%), $966,000 in FY2023 (+19.3%), $810,000 in FY2022 (+38.5%) and $585,000 in FY2021 (+54.4%).
- The Q2 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q3 2022.
- Compared with a year earlier, Other Accumulated Expenses was higher in seven of the last eight quarters, with growth averaging 68.4%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q1 2026 (growth of 280.8%); the worst was Q2 2022 (a decline of 86.8%).
- Per Business Quant data, IMUX's Other Accumulated Expenses in the three quarters before Q2 2026 was $4.92 million (Q1 2026), $1.84 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Immunic | 338.41 Mn | 338.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 743,000.00 |
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 960,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 923,000.00 |
| Jun 30, 2023 | 928,000.00 |
| Mar 31, 2023 | 878,000.00 |
| Dec 31, 2022 | 810,000.00 |
| Sep 30, 2022 | 719,000.00 |
| Jun 30, 2022 | 544,000.00 |
| Mar 31, 2022 | 649,000.00 |
| Dec 31, 2021 | 585,000.00 |
| Sep 30, 2021 | 579,000.00 |
API Access
Immunic Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IMUX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();